Evidence map›Paper›PMID 36851506›Full record

ArticleViruses2023

Change in Rotavirus Vaccine Coverage in Brazil from before (2015-2019) through the COVID-19 Pandemic Period (2020-2021).

Larissa Lima Barros, Luana Lima Barros, Rodrigo Feliciano do Carmo, Márcio Bezerra Santos, Anderson da Costa Armstrong, Rebeca Araújo de Vasconcelos, Carlos Dornels Freire de Souza

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Larissa Lima BarrosCollegiate of Medicine, Federal University of the São Francisco Valley (UNIVASF), Petrolina 56304-917, Brazil.
Luana Lima BarrosSchool of Medicine, Faculty of Medicine of Juazeiro do Norte-FMJ/IDOMED, Juazeiro do Norte 63048-080, Brazil.
Rodrigo Feliciano do CarmoCollegiate of Pharmacy, Federal University of the São Francisco Valley (UNIVASF), Petrolina 56304-917, Brazil.ORCID 0000-0001-9601-6995
Márcio Bezerra SantosCollegiate of Nursing, Federal University of Alagoas, Arapiraca 57309-000, Brazil.
Anderson da Costa ArmstrongCollegiate of Medicine, Federal University of the São Francisco Valley (UNIVASF), Petrolina 56304-917, Brazil.ORCID 0000-0003-3161-8922
Rebeca Araújo de VasconcelosCollegiate of Medicine, Federal University of the São Francisco Valley (UNIVASF), Petrolina 56304-917, Brazil.
Carlos Dornels Freire de SouzaCollegiate of Medicine, Federal University of the São Francisco Valley (UNIVASF), Petrolina 56304-917, Brazil.ORCID 0000-0001-7995-1893

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the COVID-19 pandemic, a reduction in vaccination coverage of children and adolescents was observed in several countries. The aim of this study was to assess the impact of the pandemic, in the first two years, on human rotavirus vaccine (HRV) coverage in Brazil compared with previous years. The number of doses of HRV administered in the period from January 2015 to December 2021 and its annual vaccination coverage were analyzed. The vaccination coverage decreased to 77.3% in 2020 and to 70.4% in 2021, substantially lower than the minimum that would be expected (89.2%); the decline was more pronounced in the second year of the pandemic despite the fact that in this period, the circulation restrictions were already less tight. Of the five Brazilian macro-regions, the northeast had the largest decline, and the south had the smallest impact on coverage. At the municipal level, less than half of the Brazilian municipalities managed to achieve vaccination coverage above 90% in either pandemic year. Although there was already a downward trend in coverage in the pre-pandemic years, the present study shows that the values recorded in 2020 and 2021 were significantly lower. Monitoring of vaccination coverage in the coming years should be carried out continuously in order to avoid a possible resurgence of rotavirus-induced diarrhea.

Indexed as

COVID-19RotavirusRotavirus VaccinesAdolescentBrazilChildHumansPandemicsVaccinationRotavirus VaccinesBrazilCOVID-19rotavirusvaccine

Identifiers

PMID36851506
PMCPMC9959531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.